Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Manufacturing Services Framework Agreement

19 Apr 2022 07:00

RNS Number : 5035I
Microsaic Systems plc
19 April 2022
 

19 April 2022

 

Microsaic Systems PLC

 

("Microsaic" or "the Company")

Microsaic signs new manufacturing services frameworkand an initial contract worth £400k with Innovenn UK Limited

Microsaic now supplying services for Multi-Sensor Upgradesof Environmental and Human Health Diagnostic Equipment

 

Microsaic plc (AIM: MSYS) has signed a new framework agreement with, and an initial contract worth £400,000 from, Innovenn UK Limited, a division of DeepVerge plc ("DeepVerge"), to refine and miniaturise existing monitoring equipment for environmental and human health diagnostics (the "Manufacturing Services Framework Agreement" or "MSFA").

 

The MSFA framework sets out the terms and conditions for Microsaic to improve and manufacture certain DeepVerge products and to provide the design, assembly, quality, and project management functions necessary to produce and ship equipment based on DeepVerge approved specifications, design, and quality requirements.

 

The MSFA extends the parties' existing relationship which was formalised in the 3-year framework agreement announced on 24 March 2021[i], under which Microsaic supplies its own miniaturised mass spectrometry equipment and services on a non-exclusive basis across DeepVerge's global sales, marketing and distribution channels, for healthcare diagnostic and environmental health applications.1

 

Further manufacturing services contracts with DeepVerge may follow under the new MSFA, subject to satisfactory execution of the initial contract and mutual agreement.

 

The mutual goals under the MSFA include ensuring the timely availability of quality products and in the desired quantities, as well as meeting high workmanship and quality standards and ensuring delivery needs are met. Furthermore, DeepVerge and Microsaic will jointly strive to achieve value pricing consistent with prudent practices to balance costs and the availability of services materials.

 

Additional disclosure is made below in relation to AIM Rule 13.

 

Gerard Brandon, Acting Executive Chairman of Microsaic Systems plc, commented:

"Microsaic's business model has been transitioned to offer additional services which leverage the considerable depth and breadth of technical design, engineering and delivery expertise within its team. This new framework diversifies the Company's revenues beyond equipment sales of Mass Spectrometers. By offering the skillsets that created the smallest compact mass spectrometer in the world, partner customers such as DeepVerge can outsource their engineering development of existing and new monitoring equipment and concentrate on growing their business. This new agreement illustrates how Microsaic is able to access additional revenues from other innovative companies seeking a high quality product design, development and manufacturing service."

 

Microsaic Systems plc

Gerry Brandon, Acting Executive Chairman

 

+44 (0)734 0055 648

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

 

 

 

Related Party Transaction:

As set out above, an initial order for £400,000 has been placed in accordance with the terms of the MSFA under an agreed statement of work covering the specified supply of services and product. This new contract falls outside the scope of the existing framework agreement between the two companies.

 

The MSFA and the associated new order constitute a related party transaction for the Company under AIM Rule 13, as Microsaic directors Gerard Brandon (Acting Executive Chairman) and Nigel Burton (Non-executive Director) are also Executive Chairman and Non-executive Director, respectively, of DeepVerge.

 

The independent director (Robert Moore) considers, having consulted with Singer Capital Markets as the Company's nominated adviser, that the terms of MSFA and the associated new contract are fair and reasonable insofar as the Microsaic shareholders are concerned.

 

Market Abuse Regulation (MAR) Disclosure

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

About Microsaic

Microsaic develops and commercialises micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow, or in frontline environmental monitoring

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin.

 

 

[i] https://www.londonstockexchange.com/news-article/MSYS/framework-services-agreement-update/14911251 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEAELPFDXAEAA
Date   Source Headline
13th Feb 20257:00 amRNSChange of Name Effective
6th Feb 20257:00 amRNSBoard Changes
14th Jan 20257:00 amRNSOperational Update
12th Dec 20247:00 amRNSResult of AGM, Update & Change of Name
26th Nov 20247:00 amRNSOperational Update
14th Nov 20247:00 amRNSNotice of AGM
12th Nov 20247:30 amRNSRestoration - Microsaic Systems plc
12th Nov 20247:26 amRNSRestoration
12th Nov 20247:00 amRNSHalf-year Report
5th Nov 20243:54 pmRNSUpdate on Publication of Interim Results
11th Oct 20247:00 amRNSFinal Results
24th Jul 20247:00 amRNSUpdate re. Publication of Annual Report & Accounts
1st Jul 20247:30 amRNSSuspension - Microsaic Systems plc
25th Jun 20248:06 amRNSCompany Update
19th Jun 20247:00 amRNSPublication of Annual Report & Accounts
14th Jun 20247:00 amRNSNew Product Development
2nd May 20247:00 amRNSCompany Update
27th Mar 20248:49 amRNSCompany Update
16th Feb 20247:00 amRNSCompany Update
25th Jan 20247:00 amRNSCompletion of Acquisition
23rd Jan 20241:30 pmRNSHolding(s) in Company
18th Jan 20246:15 pmRNSHolding(s) in Company
18th Jan 20243:15 pmRNSHolding(s) in Company
18th Jan 202412:00 pmRNSHolding(s) in Company
18th Jan 202410:05 amRNSHolding(s) in Company
16th Jan 20247:30 amRNSRestoration - Microsaic Systems PLC
16th Jan 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSFinal Results
16th Jan 20247:00 amRNSRestoration & Update
15th Jan 20243:45 pmRNSConditional Placing
12th Jan 20244:15 pmRNSAcquisition, Update & Change of Registered Office
4th Jan 20247:00 amRNSUpdate
29th Dec 202311:41 amRNSResult of General Meeting
22nd Dec 20231:27 pmRNSAcquisition & Fundraise Update, Revised Timetable
20th Dec 20233:03 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
20th Dec 202312:30 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
14th Dec 20237:00 amRNSUpdate on Financing, GM & Prospective Acquisition
4th Dec 20237:00 amRNSPublication of Circular and Notice of GM
13th Nov 20238:42 amRNSFunding Update
6th Nov 20237:00 amRNSFunding & Operational Update, Intention to Delist
3rd Nov 20231:32 pmRNSFunding & Operational Update, Intention to Delist
25th Sep 20237:00 amRNSUpdate and Directorate change
3rd Jul 20237:30 amRNSSuspension - Microsaic Systems PLC
29th Jun 20234:00 pmRNSAnnual Financial Report
26th Jun 20237:15 amRNSDeepVerge: debtor update
15th May 20237:15 amRNSAudit update
18th Apr 20237:59 amRNSDeepVerge plc debtor
13th Mar 202310:10 amRNSHolding(s) in Company
28th Dec 20229:25 amRNSHolding(s) in Company
24th Nov 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.